Our approach
An integrated process for drug development
We’re combining deep biological insights with cutting edge advances in computational modeling to identify drug candidates with high efficacy and low toxicity.
Our targets
Pancreatic cancer
We’re using unprecedented insights into pancreatic cancer biology to develop new treatments with wider therapeutic windows
Mycobacterial infections
Through our advanced drug discovery pipeline, we are identifying new antibiotics to eradicate these drug tolerant pathogens